Table 2 Metabolic pathways significantly enriched for differences between control and docetaxel treated OCCs
From: Distinct metabolic responses of an ovarian cancer stem cell line
KEGG pathway | Raw p | FDR |
|---|---|---|
Tyrosine metabolism | 1.03E-03 | 0.030 |
Butanoate metabolism | 1.87E-03 | 0.030 |
Phenylalanine metabolism | 1.93E-03 | 0.030 |
Citrate cycle (TCA cycle) | 3.35E-03 | 0.037 |
Glutathione metabolism | 6.36E-03 | 0.037 |
Nicotinate and nicotinamide metabolism | 6.60E-03 | 0.037 |
Thiamine metabolism | 7.52E-03 | 0.037 |
Alanine, aspartate and glutamate metabolism | 7.73E-03 | 0.037 |
Pyrimidine metabolism | 9.01E-03 | 0.038 |
Arginine and proline metabolism | 0.011 | 0.038 |
Beta-Alanine metabolism | 0.012 | 0.038 |
Pantothenate and CoA biosynthesis | 0.012 | 0.038 |
Aminoacyl-tRNA biosynthesis | 0.013 | 0.038 |
Nitrogen metabolism | 0.016 | 0.046 |
Purine metabolism | 0.017 | 0.046 |